Redmile Group’s Achilles Therapeutics ACHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$1.83M Hold
2024
Q3
$1.64M Hold
2024
Q2
$1.31M Hold
2024
Q1
$2.01M Hold
2023
Q4
$1.43M Hold
2023
Q3
$1.46M Hold
2023
Q2
$1.52M Hold
2023
Q1
$1.54M Hold
2022
Q4
$1.45M Hold
2022
Q3
$3.63M Hold
2022
Q2
$4.05M Hold
2022
Q1
$4.73M Sell
2021
Q4
$10.5M Hold
2021
Q3
$16.3M Hold
2021
Q2
$20.4M Hold
2021
Q1
$34.6M Buy